Frailty assessment tools and comorbidity indices play a crucial role, particularly in predicting outcomes for elderly patients undergoing emergency surgery. The Emergency Surgery Frailty Index (EmSFI), Charlson Comorbidity Index (CCI), and the Flemish version of the Triage Risk Screening Tool (fTRST) are considered valuable tools that help understand patients perioperative risk profiles. This study aims to investigate the accuracy and clinical utility of these scoring systems in predicting mortality in individuals aged 65 and older undergoing emergency surgery
Who can participate
Age range
65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria Patients aged 65 years and older who underwent emergency abdominal surgery
Exclusion Criteria:
* Multiple hospitalizations for the same pathology,
* Initial admission at another facility,
* History of emergency abdominal surgery before the study period,
* Terminal-stage cancer
* Emergency reoperations following elective surgery,
* Surgery while in the intensive care unit.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Predicting 30-Day Mortality in Elderly Emergency Surgery Patients: A Comparative Study of CCI, EmSFI, and fTRST Scoring Systems
Timeframe: From enrollment to the postoperative at 1 month
Trial details
NCT IDNCT06943924
SponsorDr. Lutfi Kirdar Kartal Training and Research Hospital